Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Saunders

Showing results (221-230 of 276) with videos related to

Pageof 28
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonistsAndrew G Cole, Ilana L Stroke, Lan-Ying Qin, et al.
Journal of Medicinal Chemistry|June 23, 2006
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic propertiesBrian Dyck, Stacy Markison, Liren Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5Martin W Rowbottom, Fabio C Tucci, Patrick J Connors, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activityChen Chen, Yongsheng Chen, Joseph Pontillo, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Melissa Arellano, et al.
Nephrology (Carlton, Vic.)|May 26, 2018
Identifying and integrating patient and caregiver perspectives in clinical practice guidelines for percutaneous renal biopsyTalia Gutman, Pamela Lopez-Vargas, Karine E Manera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 26, 2019
Prevalence of new variants of <i>Chlamydia trachomatis</i> escaping detection by the Aptima Combo 2 assay, England, June to August 2019David J Roberts, Grahame S Davis, Michelle J Cole, et al.
Journal of Medicinal Chemistry|June 10, 2005
Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine coreBrian Dyck, Dimitri E Grigoriadis, Raymond S Gross, et al.
Sexually Transmitted Infections|April 30, 2021
Going beyond 'regular and casual': development of a classification of sexual partner types to enhance partner notification for STIsClaudia S Estcourt, Paul Flowers, Jackie A Cassell, et al.
Pageof 28

Showing results (221-230 of 276) with videos related to

Sort By:
Pageof 28
Bioorganic & Medicinal Chemistry Letters|September 26, 2008
Synthesis of (3,4-dimethoxyphenoxy)alkylamino acetamides as orexin-2 receptor antagonistsAndrew G Cole, Ilana L Stroke, Lan-Ying Qin, et al.
Journal of Medicinal Chemistry|June 23, 2006
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic propertiesBrian Dyck, Stacy Markison, Liren Zhao, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2004
Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5Martin W Rowbottom, Fabio C Tucci, Patrick J Connors, et al.
Bioorganic & Medicinal Chemistry Letters|November 16, 2010
Discovery of NBI-77860/GSK561679, a potent corticotropin-releasing factor (CRF1) receptor antagonist with improved pharmacokinetic propertiesJohn E Tellew, Marion Lanier, Manisha Moorjani, et al.
Bioorganic & Medicinal Chemistry Letters|April 30, 2008
Potent and orally bioavailable zwitterion GnRH antagonists with low CYP3A4 inhibitory activityChen Chen, Yongsheng Chen, Joseph Pontillo, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2004
Structure-activity relationships of piperazinebenzylamines as potent and selective agonists of the human melanocortin-4 receptorJoseph Pontillo, Joseph A Tran, Melissa Arellano, et al.
Nephrology (Carlton, Vic.)|May 26, 2018
Identifying and integrating patient and caregiver perspectives in clinical practice guidelines for percutaneous renal biopsyTalia Gutman, Pamela Lopez-Vargas, Karine E Manera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 26, 2019
Prevalence of new variants of <i>Chlamydia trachomatis</i> escaping detection by the Aptima Combo 2 assay, England, June to August 2019David J Roberts, Grahame S Davis, Michelle J Cole, et al.
Journal of Medicinal Chemistry|June 10, 2005
Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine coreBrian Dyck, Dimitri E Grigoriadis, Raymond S Gross, et al.
Sexually Transmitted Infections|April 30, 2021
Going beyond 'regular and casual': development of a classification of sexual partner types to enhance partner notification for STIsClaudia S Estcourt, Paul Flowers, Jackie A Cassell, et al.
Pageof 28